The FDA will convene its Digital Health Advisory Committee Nov. 6 to discuss the use of generative artificial ...

DNA-encoded library (DEL) screening has become a standard tool in small-molecule drug discovery. Yet, even as its adoption ...

This session will highlight new research focused on optimizing AAV6 upstream production - an essential step in improving the safety and affordability of gene therapies.

Antibody-drug conjugates (ADCs) and other next-generation drug modalities are unlocking new treatment possibilities. However, ...

The Compliance Team is hosting a webinar with Elena Jacques, diversion program specialist with the Drug Enforcement Administration, Diversion Control Division, on Thursday, Aug. 14, from 2:00 pm – ...

The FDA is moving to scale back its long-standing use of expert panels to review drug applications, KFF Health News reported Sept. 12. George Tidmarsh, MD, PhD, director of the FDA’s Center for Drug ...